IL17RA and hepatocellular carcinoma: Next, to determine whether IL-17 derived from M2-TAMs reduced oxaliplatin-induced HCC cell apoptosis, we used shRNAs to generate IL-17R knockdown cells (HepG2-sh-IL-17R) or control cells (HepG2-sh-NC) (Figure 4D and 4E).